A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking

Journal of Structural Biology

Volumn 185, Issue 3, 2014, Pages 327-335

  Sowmya, Gopichandran ^a   Khan, Javed Mohammed ^a   Anand, Samyuktha ^a   Ahn, Seong Beom ^a   Baker, Mark S ^a   Ranganathan, Shoba ^a,b  

^a MACQUARIE UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Integrin v 6; Integrin heterodimer; Molecular docking; Protein protein interactions; Structural modelling; UPAR

Indexed keywords

INTEGRIN HETERODIMER; INTEGRIN ΑVΒ6; MOLECULAR DOCKING; PROTEIN-PROTEIN INTERACTIONS; STRUCTURAL MODELLING; UPAR;

ANTIGENS, NEOPLASM; HUMANS; INTEGRINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84894451766     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2014.01.001     Document Type: Article

References (64)

1. Abagyan R.A.T., Kuznetsov M.M.D.A. ICM: a new method for protein modelling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput. Chem. 1994, 15:488-506.
2. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
3. Arnaout M.A., Goodman S.L., Xiong J.P. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 2007, 19:495-507.
4. Bandyopadhyay A., Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr. Drug Targets 2009, 10:645-652.
5. Barczyk M., Carracedo S., Gullberg D. Integrins. Cell Tissue Res. 2010, 339:269-280.
6. Bates R.C., Bellovin D.I., Brown C., Maynard E., Wu B., Kawakatsu H., Sheppard D., Oettgen P., Mercurio A.M. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 2005, 115:339-347.
7. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 2000, 28:235-242.
8. Bhattacharya A., Tejero R., Montelione G.T. Evaluating protein structures determined by structural genomics consortia. Proteins 2007, 66:778-795.
9. Binder M., Trepel M. Drugs targeting integrins for cancer therapy. Expert Opin. Drug Dis. 2009, 4:229-241.
10. Blomberg N., Gabdoulline R.R., Nilges M., Wade R.C. Classification of protein sequences by homology modelling and quantitative analysis of electrostatic similarity. Proteins 1999, 37:379-387.
11. Breuss J.M., Gallo J., DeLisser H.M., Klimanskaya I.V., Folkesson H.G., Pittet J.F., Nishimura S.L., Aldape K., Landers D.V., Carpenter W., et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelling. J. Cell Sci. 1995, 108(Pt 6):2241-2251.
12. Busk M., Pytela R., Sheppard D. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J. Biol. Chem. 1992, 267:5790-5796.
13. Campbell I.D., Humphries M.J. Integrin structure, activation, and interactions. Cold Spring Harb. Perspect. Biol. 2011, 3.
14. Chaurasia P., Aguirre-Ghiso J.A., Liang O.D., Gardsvoll H., Ploug M., Ossowski L. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J. Biol. Chem. 2006, 281:14852-14863.
15. Chaurasia P., Mezei M., Zhou M.M., Ossowski L. Computer aided identification of small molecules disrupting uPAR/alpha5beta1-integrin interaction: a new paradigm for metastasis prevention. PLoS One 2009, 4:e4617.
16. Degryse B., Resnati M., Czekay R.P., Loskutoff D.J., Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J. Biol. Chem. 2005, 280:24792-24803.
17. Diago L.A., Morell P., Aguilera L., Moreno E. Setting up a large set of protein-ligand PDB complexes for the development and validation of knowledge-based docking algorithms. BMC Bioinformatics 2007, 8:310.
18. Eden G., Archinti M., Furlan F., Murphy R., Degryse B. The urokinase receptor interactome. Curr. Pharm. Des. 2011, 17:1874-1889.
19. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
20. Hooft R.W., Vriend G., Sander C., Abola E.E. Errors in protein structures. Nature 1996, 381:272.
21. Huai Q., Zhou A., Lin L., Mazar A.P., Parry G.C., Callahan J., Shaw D.E., Furie B., Furie B.C., Huang M. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nat. Struct. Mol. Biol. 2008, 15:422-423.
22. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 2000, 28:311-339.
23. Huynh T., Khan J.M., Ranganathan S. A comparative structural bioinformatics analysis of inherited mutations in beta-d-Mannosidase across multiple species reveals a genotype-phenotype correlation. BMC Genomics 2011, 12(Suppl. 3):S22.
24. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
25. Hynes R.O. The emergence of integrins: a personal and historical perspective. Matrix Biol. 2004, 23:333-340.
26. Khan J.M., Ranganathan S. A multi-species comparative structural bioinformatics analysis of inherited mutations in alpha-d-mannosidase reveals strong genotype-phenotype correlation. BMC Genomics 2009, 10(Suppl. 3):S33.
27. Kim C., Ye F., Ginsberg M.H. Regulation of integrin activation. Annu. Rev. Cell Dev. Biol. 2011, 27:321-345.
28. Laskowski R.A. PDBsum new things. Nucleic Acids Res. 2009, 37:D355-359.
29. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 1996, 8:477-486.
30. Lee B., Richards F.M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 1971, 55:379-400.
31. Llinas P., Le Du M.H., Gardsvoll H., Dano K., Ploug M., Gilquin B., Stura E.A., Menez A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J. 2005, 24:1655-1663.
32. Lo Conte L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 1999, 285:2177-2198.
33. Lu X., Lu D., Scully M., Kakkar V. The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. Perspect. Med. Chem. 2008, 2:57-73.
34. Margadant C., Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010, 11:97-105.
35. Morgan M.R., Thomas G.J., Russell A., Hart I.R., Marshall J.F. The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9. J. Biol. Chem. 2004, 279:26533-26539.
36. Morris D.G., Huang X., Kaminski N., Wang Y., Shapiro S.D., Dolganov G., Glick A., Sheppard D. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003, 422:169-173.
37. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., Sheppard D. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
38. Nagae M., Re S., Mihara E., Nogi T., Sugita Y., Takagi J. Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor. J. Cell Biol. 2012, 197:131-140.
39. Neves M.A., Totrov M., Abagyan R. Docking and scoring with ICM: the benchmarking results and strategies for improvement. J. Comput. Aided Mol. Des. 2012, 26:675-686.
40. Ossowski L., Aguirre-Ghiso J.A. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 2000, 12:613-620.
41. Porollo A., Meller J. Prediction-based fingerprints of protein-protein interactions. Proteins 2007, 66:630-645.
42. Ranganathan S. Molecular modelling on the web. Biotechniques 2001, 30:50-52.
43. Richter S., Wenzel A., Stein M., Gabdoulline R.R., Wade R.C. WebPIPSA: a web server for the comparison of protein interaction properties. Nucleic Acids Res. 2008, 36:W276-280.
44. Saldanha R.G., Molloy M.P., Bdeir K., Cines D.B., Song X., Uitto P.M., Weinreb P.H., Violette S.M., Baker M.S. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy. J. Proteome Res. 2007, 6:1016-1028.
45. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993, 234:779-815.
46. Sanchez R., Sali A. Advances in comparative protein-structure modelling. Curr. Opin. Struct. Biol. 1997, 7:206-214.
47. Sander C., Schneider R. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins 1991, 9:56-68.
48. Simon D.I., Wei Y., Zhang L., Rao N.K., Xu H., Chen Z., Liu Q., Rosenberg S., Chapman H.A. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 2000, 275:10228-10234.
49. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 2010, 11:23-36.
50. Sowmya G., Anita S., Kangueane P. Insights from the structural analysis of protein heterodimer interfaces. Bioinformation 2011, 6:137-143.
51. Takada Y., Ye X., Simon S. The integrins. Genome Biol. 2007, 8:215.
52. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
53. Tng E., Tan S.M., Ranganathan S., Cheng M., Law S.K. The integrin alpha L beta 2 hybrid domain serves as a link for the propagation of activation signal from its stalk regions to the I-like domain. J. Biol. Chem. 2004, 279:54334-54339.
54. Tsodikov O.V., Record M.T., Sergeev Y.V. Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J. Comput. Chem. 2002, 23:600-609.
55. UniProt Consortium Activities at the Universal Protein Resource (UniProt). Nucl. Acids Res. 2014, 42:D191-D198.
56. Van Aarsen L.A., Leone D.R., Ho S., Dolinski B.M., McCoon P.E., LePage D.J., Kelly R., Heaney G., Rayhorn P., Reid C., Simon K.J., Horan G.S., Tao N., Gardner H.A., Skelly M.M., Gown A.M., Thomas G.J., Weinreb P.H., Fawell S.E., Violette S.M. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res. 2008, 68:561-570.
57. Xie C., Zhu J., Chen X., Mi L., Nishida N., Springer T.A. Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J. 2010, 29:666-679.
58. Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 2001, 294:339-345.
59. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 2002, 296:151-155.
60. Xiong J.P., Mahalingham B., Alonso J.L., Borrelli L.A., Rui X., Anand S., Hyman B.T., Rysiok T., Muller-Pompalla D., Goodman S.L., Arnaout M.A. Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J. Cell Biol. 2009, 186:589-600.
61. Yang J., Ma Y.Q., Page R.C., Misra S., Plow E.F., Qin J. Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc. Natl. Acad. Sci. USA 2009, 106:17729-17734.
62. Yu Y., Zhu J., Mi L.Z., Walz T., Sun H., Chen J., Springer T.A. Structural specializations of alpha(4)beta(7), an integrin that mediates rolling adhesion. J. Cell Biol. 2012, 196:131-146.
63. Zhang F., Tom C.C., Kugler M.C., Ching T.T., Kreidberg J.A., Wei Y., Chapman H.A. Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J. Cell Biol. 2003, 163:177-188.
64. Zhu J., Luo B.H., Xiao T., Zhang C., Nishida N., Springer T.A. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell 2008, 32:849-861.